Gehan Ahmed Mostafa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gehan Ahmed Mostafa has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Laila Yousef Al-Ayadhi
Autism Research and Treatment Center, King Saud University, Riyadh 11461, Saudi Arabia
11 shared publications Abeer A. Shehab
3 shared publicationsA. Mokhtar
Community, Environmental, and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publicationAbeer Al Shehab
Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publicationAzza K. Mohammed
1 shared publicationDalia H. Ibrahim
1 shared publication
Latest Publications
- 1 August 2013
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 261 (1-2) , 77-81
The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children
- 1 August 2013
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 261 (1-2) , 77-81
The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children
- Open Access
- 19 June 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 1-72
Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children
In some autistic children, there is an imbalance of T helper (Th)1/Th2 lymphocytes toward Th2, which may be responsible for the induction of the production of autoantibodies in these children. Th2 lymphocytes express CCR4 receptors. CCR4 ligands include macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). They direct trafficking and recruitment of Th2 cells. We are the first to measure serum levels of CCR4 ligands in relation to the degree of the severity of autism.
- 19 June 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 1-72
Open AccessElevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children
In some autistic children, there is an imbalance of T helper (Th)1/Th2 lymphocytes toward Th2, which may be responsible for the induction of the production of autoantibodies in these children. Th2 lymphocytes express CCR4 receptors. CCR4 ligands include macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). They direct trafficking and recruitment of Th2 cells. We are the first to measure serum levels of CCR4 ligands in relation to the degree of the severity of autism.
- 1 February 2013
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 255 (1-2) , 70-74
The link between some alleles on human leukocyte antigen system and autism in children
- 1 February 2013
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 255 (1-2) , 70-74
The link between some alleles on human leukocyte antigen system and autism in children
- 1 September 2012
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 16 (5) , 464-468
The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children
- 1 September 2012
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 16 (5) , 464-468
The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children
- Open Access
- 17 August 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 201
Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity
Aside from the skeletal health affection, vitamin D deficiency has been implicated as a potential environmental factor triggering for some autoimmune disorders. Vitamin D might play a role in the regulation of the production of auto-antibodies. Immunomodulatory effects of vitamin D may act not only through modulation of T-helper cell function, but also through induction of CD4+CD25high regulatory T-cells. We are the first to investigate the relationship between serum levels of 25-hydroxy vitamin D and anti-myelin-associated glycoprotein (anti-MAG) auto-antibodies in autistic children.
- 17 August 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 201
Open AccessReduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity
Aside from the skeletal health affection, vitamin D deficiency has been implicated as a potential environmental factor triggering for some autoimmune disorders. Vitamin D might play a role in the regulation of the production of auto-antibodies. Immunomodulatory effects of vitamin D may act not only through modulation of T-helper cell function, but also through induction of CD4+CD25high regulatory T-cells. We are the first to investigate the relationship between serum levels of 25-hydroxy vitamin D and anti-myelin-associated glycoprotein (anti-MAG) auto-antibodies in autistic children.
- Open Access
- 2 July 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 158
Elevated serum levels of interleukin-17A in children with autism
The T-helper (Th)1/Th2 dichotomy dominated the field of immune regulation until interleukin (IL)-17-expressing T cells (Th17) were proposed to be a third lineage of helper T cells, the key players in the pathogenesis of autoimmune disorders. Autoimmunity to brain tissue may play a pathogenic role in autism. IL-17A is a pro-inflammatory cytokine that has been shown to play an important role in various autoimmune neuroinflammatory diseases. The aim of this study was to measure serum levels of IL-17A in relation to the degree of the severity of autism.
- 2 July 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 158
Open AccessElevated serum levels of interleukin-17A in children with autism
The T-helper (Th)1/Th2 dichotomy dominated the field of immune regulation until interleukin (IL)-17-expressing T cells (Th17) were proposed to be a third lineage of helper T cells, the key players in the pathogenesis of autoimmune disorders. Autoimmunity to brain tissue may play a pathogenic role in autism. IL-17A is a pro-inflammatory cytokine that has been shown to play an important role in various autoimmune neuroinflammatory diseases. The aim of this study was to measure serum levels of IL-17A in relation to the degree of the severity of autism.
- Open Access
- 16 March 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 54
A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children
S100B is a calcium-binding protein that is produced primarily by astrocytes. Increased serum S100B protein levels reflect neurological damage. Autoimmunity may have a role in the pathogenesis of autism in some patients. Autoantibodies may cross the blood-brain barrier and combine with brain tissue antigens, forming immune complexes and resulting in neurological damage. We are the first to investigate the relationship between serum levels of S100B protein, a marker of neuronal damage, and antiribosomal P protein antibodies in autistic children.
- 16 March 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 54
Open AccessA lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children
S100B is a calcium-binding protein that is produced primarily by astrocytes. Increased serum S100B protein levels reflect neurological damage. Autoimmunity may have a role in the pathogenesis of autism in some patients. Autoantibodies may cross the blood-brain barrier and combine with brain tissue antigens, forming immune complexes and resulting in neurological damage. We are the first to investigate the relationship between serum levels of S100B protein, a marker of neuronal damage, and antiribosomal P protein antibodies in autistic children.
- Open Access
- 1 January 2011
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 8 (1) , 71
A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children
One of the most consistent biological findings in autism is the elevated blood serotonin levels. Immune abnormalities, including autoimmunity with production of brain specific auto-antibodies, are also commonly observed in this disorder. Hyperserotonemia may be one of the contributing factors to autoimmunity in some patients with autism through the reduction of T-helper (Th) 1-type cytokines. We are the first to investigate the possible role of hyperserotonemia in the induction of autoimmunity, as indicated by serum anti-myelin-basic protein (anti-MBP) auto-antibodies, in autism.
- 1 January 2011
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 8 (1) , 71
Open AccessA lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children
One of the most consistent biological findings in autism is the elevated blood serotonin levels. Immune abnormalities, including autoimmunity with production of brain specific auto-antibodies, are also commonly observed in this disorder. Hyperserotonemia may be one of the contributing factors to autoimmunity in some patients with autism through the reduction of T-helper (Th) 1-type cytokines. We are the first to investigate the possible role of hyperserotonemia in the induction of autoimmunity, as indicated by serum anti-myelin-basic protein (anti-MBP) auto-antibodies, in autism.
- Open Access
- 1 January 2011
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 8 (1) , 39
Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity
Autoimmunity to the central nervous system (CNS) may play a pathogenic role in a subgroup of patients with autism. This study aimed to investigate the frequency of serum anti-ganglioside M1 auto-antibodies, as indicators of the presence of autoimmunity to CNS, in a group of autistic children. We are the first to measure the relationship between these antibodies and the degree of the severity of autism.
- 1 January 2011
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 8 (1) , 39
Open AccessIncreased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity
Autoimmunity to the central nervous system (CNS) may play a pathogenic role in a subgroup of patients with autism. This study aimed to investigate the frequency of serum anti-ganglioside M1 auto-antibodies, as indicators of the presence of autoimmunity to CNS, in a group of autistic children. We are the first to measure the relationship between these antibodies and the degree of the severity of autism.
- Open Access
- 1 January 2011
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 8 (1) , 180
The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism
Neurogenic inflammation is orchestrated by a large number of neuropeptides. Tachykinins (substance P, neurokinin A and neurokinin B) are pro-inflammatory neuropeptides that may play an important role in some autoimmune neuroinflammatory diseases. Autoimmunity may have a role in the pathogenesis of autism in some patients. We are the first to measure serum neurokinin A levels in autistic children. The relationship between serum levels of neurokinin A and anti-ribosomal P protein antibodies was also studied.
- 1 January 2011
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 8 (1) , 180
Open AccessThe possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism
Neurogenic inflammation is orchestrated by a large number of neuropeptides. Tachykinins (substance P, neurokinin A and neurokinin B) are pro-inflammatory neuropeptides that may play an important role in some autoimmune neuroinflammatory diseases. Autoimmunity may have a role in the pathogenesis of autism in some patients. We are the first to measure serum neurokinin A levels in autistic children. The relationship between serum levels of neurokinin A and anti-ribosomal P protein antibodies was also studied.